Omidria Injection, Solution, Concentrate
Product Images NDC 62225-600

5 FDA label images from Omeros Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Omidria (NDC 62225-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Omeros Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Omi00 0003 01

Omi00 0003 01
Chemical structure of phenylephrine hydrochloride, showing its molecular arrangement including a benzene ring with two hydroxyl groups, an amine group, and associated hydrochloride ion.*
FDA Label Image

Omi00 0003 02

Omi00 0003 02
Chemical structure diagram depicting the molecular arrangement of phenylephrine and ketorolac, the active ingredients in Omidria injection solution concentrate.*
FDA Label Image

Omi00 0003 03

Omi00 0003 03
Line graphs showing mean pupil diameter change from baseline (in mm) over time (minutes since start of incision) for two separate studies. Both graphs compare Omidria to placebo, with Omidria maintaining a pupil diameter near baseline and placebo showing a progressive decrease over time.*
FDA Label Image

Omi00 0003 04

Omi00 0003 04
A two-part line graph comparing mean VAS (Visual Analog Scale) scores over time post surgery between Omidria and placebo groups. Study 1 and Study 2 panels display VAS scores measured in millimeters on the vertical axis and hours post surgery on the horizontal axis. Omidria shows lower VAS scores compared to placebo across all time points up to 12 hours post surgery.*
FDA Label Image

Omi00 0003 05

Omi00 0003 05
Omidria 1% / 0.3% phenylephrine and ketorolac intraocular injection solution concentrate packaging label. It is a single-patient vial, sterile 4 mL, for intraocular use and must be diluted. The labeler is Omeros Corporation, Seattle, WA. The label includes active ingredient concentrations of 10.16 mg/mL phenylephrine and 2.88 mg/mL ketorolac, along with inactive ingredients and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.